Also known as: Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-1, SNAP8
Topical anti-wrinkle cosmeceutical targeting expression lines
Amount
3-10% concentration in formulation (solution, not pure peptide)
Frequency
Twice daily (morning and evening)
Duration
Continuous use; minimum 28 days for measurable results
Route
TopicalSchedule
Twice daily (morning and evening)
Timing
Morning and evening as part of skincare routine, applied after cleansing and before moisturizer
Duration
Continuous use; minimum 28 days for measurable results
Repeatable
Yes
Storage: Store SNAP-8 solution refrigerated at 2-8C for maximum stability. Finished cosmetic products are stable at room temperature. Protect from direct sunlight and avoid contamination.
Get free access to all content plus biweekly research updates.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
SNAP-8, known chemically as Acetyl Octapeptide-3, is a synthetic peptide developed by the Spanish biotechnology company Lipotec (now part of Lubrizol Life Science) as a topical cosmeceutical ingredient for reducing expression wrinkles. It is an extension of the earlier hexapeptide Argireline (Acetyl Hexapeptide-3/8), with two additional amino acids (alanine and aspartate) added to the sequence, yielding an octapeptide with enhanced anti-wrinkle activity.
SNAP-8 belongs to the class of neurotransmitter inhibitor peptides -- synthetic sequences designed to mimic portions of proteins involved in neuromuscular junction signaling. By interfering with the molecular machinery required for neurotransmitter release, these peptides attenuate the muscle contractions responsible for dynamic facial wrinkles such as crow's feet and forehead lines.
SNAP-8 acts as a competitive antagonist of the SNARE complex, the molecular machinery that mediates synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction. Its mechanism involves several key steps:
Normal neuromuscular signaling requires the assembly of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex, consisting of three proteins:
When these three proteins assemble into the ternary SNARE complex, they generate the mechanical force needed to fuse acetylcholine-containing vesicles with the presynaptic membrane, releasing the neurotransmitter into the synaptic cleft.
SNAP-8 mimics the N-terminal domain of SNAP-25 and competes with endogenous SNAP-25 for incorporation into the SNARE complex. When SNAP-8 occupies the SNAP-25 binding site, it destabilizes the ternary complex, preventing efficient vesicle fusion and reducing acetylcholine release. This results in attenuated muscle contraction at the neuromuscular junction, softening the dynamic facial movements that create expression lines.
This mechanism is analogous to that of botulinum toxin (Botox), which cleaves SNARE proteins to prevent vesicle fusion. However, SNAP-8 achieves its effect through competitive inhibition rather than enzymatic cleavage, making it reversible and significantly less potent -- but also non-toxic and suitable for topical cosmetic application.
SNAP-8 is structurally derived from Argireline (Acetyl Hexapeptide-3), which was the first commercially successful anti-wrinkle peptide based on SNARE complex inhibition. The key differences are:
| Property | Argireline (AH-3) | SNAP-8 (AO-3) |
|---|---|---|
| Length | 6 amino acids | 8 amino acids |
| Sequence | Ac-EEMQRR-NH2 | Ac-EEMQRRAD-NH2 |
| SNARE inhibition | Moderate | Enhanced (~30% more active) |
| Clinical data | More extensive | Growing evidence base |
| Market availability | Widely available | Available but less common |
Both peptides target the same molecular mechanism, but in vitro and in vivo testing suggests that SNAP-8 is approximately 30% more active than Argireline at equivalent concentrations.
Clinical evaluations of SNAP-8 have demonstrated measurable anti-wrinkle effects when applied topically:
These results, while promising, should be interpreted with caution. Most clinical efficacy data comes from manufacturer-sponsored studies, and the magnitude of wrinkle reduction, while statistically significant, is substantially less than that achieved by botulinum toxin injection.
A significant limitation of all topical peptides, including SNAP-8, is their limited ability to penetrate the stratum corneum. Due to its hydrophilic nature and relatively large molecular size (1075 Da), SNAP-8 faces challenges in achieving therapeutic concentrations in the deeper skin layers where the neuromuscular junctions reside.
Research has focused on enhancing delivery through:
SNAP-8 is typically supplied as a solution (SNAP-8 Peptide Solution C by Lipotec) containing the peptide in an aqueous base. Recommended concentrations in cosmetic formulations range from 3-10%, with higher concentrations showing greater efficacy in clinical testing.
The peptide demonstrates good stability in typical cosmetic formulations across a range of pH values and is compatible with most common cosmetic ingredients. It can be incorporated into serums, creams, eye contour treatments, and other leave-on products.
While SNAP-8 and botulinum toxin share a mechanistic target (the SNARE complex), they differ fundamentally in approach:
SNAP-8 is best understood as a cosmetic maintenance ingredient rather than a medical treatment, offering modest but measurable wrinkle reduction suitable for daily skincare routines.
A synthetic hexapeptide (Argireline) with antiwrinkle activity, published in International Journal of Cosmetic Science (Blanes-Mira C et al., 2002; PMID: 18498523):
The anti-wrinkle efficacy of argireline in Chinese subjects: a randomized placebo-controlled study, published in Journal of Cosmetic and Laser Therapy (Wang Y et al., 2013; PMID: 23417317):
We summarize new studies, safety updates, and dosing insights โ delivered biweekly.
See real-world usage patterns alongside the clinical evidence above. Community-sourced, not clinically verified.
Based on 45+ community reports
View community protocolsResearch-grade suppliers verified by our scoring methodology.
Argireline (acetyl hexapeptide-8): topical SNARE complex inhibitor for dynamic wrinkle reduction. Up to 30% wrinkle depth improvement as a non-invasive Botox alternative.
Botulinum toxin: FDA-approved neurotoxin guide. Covers SNARE mechanism, Botox vs Dysport, migraine and spasticity uses, dosing, and safety profile.
GHK-Cu: Copper tripeptide for skin healing and anti-aging. Covers collagen stimulation, wound repair, hair growth, and topical vs injectable use.
Melanotan-1 (Afamelanotide): Approved alpha-MSH analog. Covers melanocortin mechanism, Scenesse for EPP, photoprotective tanning, and safety data.
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.
Evidence-based guide to cosmeceutical anti-wrinkle peptides including SNAP-8, Argireline, Matrixyl, and GHK-Cu โ mechanisms, clinical data, and formulation.
Research review of collagen-stimulating peptides for skin rejuvenation including GHK-Cu, Matrixyl, SNAP-8, and BPC-157 wound healing data.
From senolytic FOXO4-DRI to mitochondrial SS-31, we ranked 13 anti-aging peptides by clinical trial evidence across 6 mechanisms. See which have human data vs. animal-only studies.
Peptides for skin health โ GHK-Cu, SNAP-8, Melanotan-1, BPC-157, and Glutathione reviewed with evidence levels and mechanisms of action.
Related content you may find interesting